
LINK . SPRINGER . COM {
}
Title:
Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer | Breast Cancer Research and Treatment
Description:
Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Education
- Insurance
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We're unsure how the site profits.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {π}
cancer, breast, google, scholar, evaluation, serum, tumor, article, markers, patients, director, hospital, research, iwase, kobayashi, itoh, marker, privacy, cookies, treatment, advanced, nagoya, city, content, information, journal, publish, search, recurrent, cea, clinical, access, surg, data, change, log, masaoka, bca, discover, tumour, jpn, carcinoma, download, national, springer, optional, analysis, personal, parties, policy,
Topics {βοΈ}
serum tumor markers month download article/chapter breast cancer research tumour marker courses serum markers recurrent breast cancer privacy choices/manage cookies breast cancer treatments primary breast cancer metastasising breast cancer tumor markers toyokawa city hospital serum tumor marker circulating ca15-3 levels postoperative cea time breast cancer treatment serological evaluation toyota memorial hospital prognostic factors director hiroshi itoh breast cancer patients full article pdf director tetsuo hotta director kazuo shibata director hironori tanaka director katsumi nakamae european economic area sialyl-sugar residue bca225 concentrations conditions privacy policy tumor marker concentration monoclonal antibody reactive breast cancer breast cancer 7 director shoji karamatsu director koji matsuo accepting optional cookies check access instant access predictive journal finder publish cancer res 75 breast carcinoma cancer treatment cancer patient gastrointestinal cancer serum positivity related subjects tumour shunzo kobayashi
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
datePublished:
dateModified:
pageStart:83
pageEnd:88
sameAs:https://doi.org/10.1007/BF00666074
keywords:
breast cancer
CA15-3
CEA
BCA225
serological evaluation
serum markers
Oncology
image:
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Hirotaka Iwase
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Shunzo Kobayashi
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Yukashi Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Fukuoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuya Kuzushima
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroji Iwata
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Toshinari Yamashita
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Akihiro Naitoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuko Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Akira Masaoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
datePublished:
dateModified:
pageStart:83
pageEnd:88
sameAs:https://doi.org/10.1007/BF00666074
keywords:
breast cancer
CA15-3
CEA
BCA225
serological evaluation
serum markers
Oncology
image:
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Hirotaka Iwase
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Shunzo Kobayashi
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Yukashi Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Fukuoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Tatsuya Kuzushima
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroji Iwata
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Toshinari Yamashita
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Akihiro Naitoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuko Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
name:Akira Masaoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:33
Organization:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Hirotaka Iwase
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Shunzo Kobayashi
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Yukashi Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Hideki Fukuoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Tatsuya Kuzushima
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Hiroji Iwata
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Toshinari Yamashita
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Akihiro Naitoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Kazuko Itoh
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
name:Akira Masaoka
affiliation:
name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
address:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(56)
- How much does https://www.springernature.com/gp/authors make?
- How much income does https://link.springernature.com/home/ have?
- What's the financial intake of https://order.springer.com/public/cart?
- How much does https://submission.springernature.com/new-submission/10549/3 make?
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals bring in each month?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20effects%20of%20breast%20cancer%20treatments%20by%20serum%20tumor%20marker&journal=Jpn%20J%20Breast%20Cancer&volume=7&pages=356-365&publication_year=1992&author=Iwase%2CH&author=Kobayashi%2CS
- http://scholar.google.com/scholar_lookup?&title=The%20clinical%20value%20of%20serum%20CA15-3%20assay%20postoperatively%20in%20breast%20cancer%20patients&journal=Jpn%20J%20Surg&volume=19&pages=278-282&publication_year=1989&author=Kobayashi%2CS&author=Iwase%2CH&author=Karamatsu%2CS&author=Matsuo%2CK&author=Masaoka%2CA&author=Miyagawa%2CT's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=Circulating%20CA15-3%20levels%20in%20the%20postsurgical%20follow-up%20of%20breast%20cancer%20patients%20and%20in%20non-malignant%20diseases&journal=Breast%20Cancer%20Research%20and%20Treatment&volume=13&pages=123-133&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Genolla%2CJ&author=Rubio%2CD&author=DelCampo%2CJM&author=Bodi%2CR&author=Salvador%2CL pull in monthly?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20marker%20levels%20in%20advanced%20breast%20carcinoma%20correlate%20with%20the%20extent%20of%20metastatic%20disease&journal=Cancer&volume=64&pages=1674-1681&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Salvador%2CL each month?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=The%20tumour%20associated%20antigen%20CA15-3%20in%20primary%20breast%20cancer.%20Evaluation%20of%20667%20cases&journal=Br%20J%20Cancer&volume=63&pages=809-813&publication_year=1991&author=Gion%2CM&author=Mione%2CR&author=Nascimben%2CO&author=Valsecchi%2CM&author=Gatti%2CC&author=Leon%2CA&author=Bruscagnin%2CG?
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20use%20of%20CA15-3%20as%20a%20serum%20tumor%20marker%20in%20breast%20carcinoma&journal=Eur%20J%20Surg%20Oncol&volume=17&pages=16-19&publication_year=1991&author=Duncan%2CJL&author=Price%2CA&author=Rogers%2CK generate?
- How much does http://scholar.google.com/scholar_lookup?&title=CA15-3%20and%20carcinoembryonic%20antigen%20in%20the%20clinical%20evaluation%20of%20breast%20cancer&journal=Clinica%20Chimica%20Acta&volume=200&pages=81-94&publication_year=1991&author=Dnistrian%2CAM&author=Schwartz%2CMK&author=Greenberg%2CEJ&author=Smith%2CCA&author=Schwartz%2CDC pull in monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Immunocytochemical%20distribution%20of%20a%20breast%20carcinoma%20associated%20glycoprotein%20identified%20by%20monoclonal%20antibodies&journal=American%20Journal%20of%20Pathology&volume=130&pages=305-314&publication_year=1988&author=Mesa-Tejada%2CR&author=Palakodety%2CRB&author=Leon%2CJA&author=Khatcherian%2CAO&author=Greaton%2CCJ earning monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Monoclonal%20antibody%20reactive%20with%20the%20sialyl-sugar%20residue%20of%20a%20high%20molecular%20weight%20glycoprotein%20in%20sera%20of%20cancer%20patient&journal=Jpn%20J%20Cancer%20Res&volume=75&pages=485-488&publication_year=1985&author=Hirohashi%2CS&author=Watanabe%2CM&author=Shimosato%2CY is on a monthly basis
- Revenue of http://scholar.google.com/scholar_lookup?&title=Tumour%20Marker%20Courses%20to%20assess%20the%20efficacy%20of%20chemotherapy%20or%20hormone%20therapy%20in%20metastasising%20breast%20cancer&journal=Geburtsh%20u%20Frauenheilk&volume=53&pages=24-29&publication_year=1993&author=Mobus%2CV&author=Paula%2CJ&author=Beck%2CT&author=Crombach%2CG&author=Kreienberg%2CR
- See how much http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20cancer%20treatment%20by%20serum%20markers&journal=J%20Clin%20Surg&volume=47&pages=6231-628&publication_year=1992&author=Ohkura%2CH&author=Sugano%2CY&author=Shimada%2CY&author=Saitou%2CD&author=Shirao%2CK&author=Okazaki%2CN&author=Okada%2CS&author=Yoshimori%2CM makes per month
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Slope%20analysis%20of%20the%20postoperative%20CEA%20time%20course%20and%20possible%20application%20as%20an%20aid%20in%20diagnosis%20of%20disease%20progression%20in%20gastrointestinal%20cancer&journal=Am%20J%20Surg&volume=136&pages=322-327&publication_year=1978&author=Staab%2CHJ?
- How much profit is https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=references making per month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hirotaka%20Iwase produce monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hirotaka%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shunzo%20Kobayashi each month?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shunzo%20Kobayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yukashi%20Itoh's financial summary
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yukashi%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hideki%20Fukuoka pull in?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hideki%20Fukuoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tatsuya%20Kuzushima?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tatsuya%20Kuzushima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroji%20Iwata earns monthly
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroji%20Iwata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toshinari%20Yamashita income
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toshinari%20Yamashita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akihiro%20Naitoh net monthly?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akihiro%20Naitoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuko%20Itoh's total income per month
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuko%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Masaoka earning monthly?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Masaoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Discover the revenue of https://s100.copyright.com/AppDispatchServlet?title=Evaluation%20of%20serum%20tumor%20markers%20in%20patients%20with%20advanced%20or%20recurrent%20breast%20cancer&author=Hirotaka%20Iwase%20et%20al&contentID=10.1007%2FBF00666074©right=Kluwer%20Academic%20Publishers&publication=0167-6806&publicationDate=1995-01&publisherName=SpringerNature&orderBeanReset=true
- How much money does https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=citation generate?
- What's the income generated by https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral each month?
- Get to know https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's earnings
- How much profit is https://www.springernature.com/gp/products making per month?
- How much revenue does https://www.springernature.com/gp/librarians bring in?
- How much does https://www.springernature.com/gp/societies make?
- How much does https://www.springernature.com/gp/partners rake in every month?
- Discover the revenue of https://www.springer.com/
- How much does https://www.nature.com/ pull in monthly?
- How much money does https://www.biomedcentral.com/ generate?
- Revenue of https://www.palgrave.com/
- Income figures for https://www.apress.com/
- Financial intake of https://www.springernature.com/gp/legal/ccpa
- How much revenue does https://www.springernature.com/gp/info/accessibility generate?
- What are the earnings of https://support.springernature.com/en/support/home?
- What's https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's gross income?
- How much does https://www.springernature.com/ pull in monthly?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref